Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesPresent status of bronchoalveolar lavage in interstitial lung disease
Current Opinion in Pulmonary Medicine, 08/12/09
Reynolds HY – BAL findings continue to impact on understanding disease pathogenesis and this may be its major use now, BAL fluid components, cells in particular, are not correlated well with activity of disease nor for monitoring disease progress or response to treatment. For a few rarer ILDs, BAL fluid characteristics may strongly support a diagnosis.
Related Articles
Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts
Arthritis & Rheumatism, 11/11/09
Relevance Score: 69%
Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09
Relevance Score: 68%
Radiochemotherapy in small-cell lung cancer
Expert Review of Anticancer Therapy, 10/20/09
Relevance Score: 68%
Nocturnal hypoxia and sleep disturbances in cystic fibrosis
Pediatric Pulmonology, 10/14/09
Relevance Score: 68%
Risk of Acute Exacerbation After Video-assisted Thoracoscopic Lung Biopsy for Interstitial Lung Disease
Journal of Bronchology, 10/14/09
Relevance Score: 68%
Today in Restrictive Lung Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease
European Respiratory Journal , 12/11/09
Pneumonia Recovery; Discrepancies in Perspectives of the Radiologist, Physician and Patient
Journal of General Internal Medicine, 12/11/09
Pirfenidone in idiopathic pulmonary fibrosis
European Respiratory Journal , 12/10/09
Sponsor
Article Search
Sponsor
Sponsor